Meiji Yasuda Life Insurance’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,058
Closed -$273K 247
2025
Q2
$273K Sell
1,058
-325
-23% -$77.5K 0.01% 217
2025
Q1
$310K Buy
1,383
+27
+2% +$6.3K 0.01% 218
2024
Q4
$310K Buy
1,356
+60
+5% +$14.4K 0.01% 221
2024
Q3
$316K Sell
1,296
-804
-38% -$180K 0.01% 215
2024
Q2
$402K Buy
+2,100
New +$426K 0.01% 205
2016
Q1
Sell
-5,100
Closed -$274K 305
2015
Q4
$274K Buy
+5,100
New +$287K 0.04% 268
2015
Q1
Sell
-6,173
Closed -$346K 359
2014
Q4
$346K Buy
+6,173
New +$322K 0.05% 311
2013
Q4
Sell
-7,312
Closed -$386K 380
2013
Q3
$386K Buy
+7,312
New +$355K 0.07% 270

Other funds holding RMD

Meiji Yasuda Life Insurance's RMD Position: Q3 2025 in Review

Meiji Yasuda Life Insurance sold out of ResMed (RMD) in Q3 2025, closing a stake of 1,058 shares — an estimated $273K sold.

Meiji Yasuda Life Insurance first reported a position in RMD in Q3 2013 and held it in 8 quarters. The position peaked at $402K in Q2 2024. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Meiji Yasuda Life Insurance reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Meiji Yasuda Life Insurance sold 1,058 ResMed shares in Q3 2025, an estimated $273K.
  • Meiji Yasuda Life Insurance first reported a position in ResMed in Q3 2013 and held it in 8 quarters.
  • Meiji Yasuda Life Insurance's ResMed position peaked at $402K in Q2 2024.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Meiji Yasuda Life Insurance's 13F filing for Q3 2025, filed 13 Nov 2025.